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The reconfigured body
human–animal relations in xenotransplantation
The article explores issues concerning the reconfiguration of human and animal 
bodies in modern biotechnology. The examples are based on xenotransplanta-
tion: Transplantation of cells, tissue and organs from animals to humans. Three 
thematic issues that emerged from xenotransplantation research in Sweden in 
the 1990s and early 2000s are examined in the article. The first issue concerns 
how the pig was introduced as a donor animal in xenotransplantation and, at 
the same time, dehumanized in relation to what is human. Baboons and chim-
panzees that had previously been used in xenotransplantation now became an 
ethically problematic choice, and were in stead humanized. The second issue 
concerns the introduction of transgenic and cloned pigs as commoditized ob-
jects. The biotechnological development reconfigured the pig’s cells, tissue and 
organs to become more human-like. The third issue concerns the risk that pigs 
contain retrovirus that could infect the transplanted patients. The human body 
became part of a network of both animal and retrovirus. Boundlessness between 
human and animal bodies appears in these three thematic phases and is analysed 
from a cultural perspective.
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introduction
Modern biotechnology is a central field where different biological objects are reconfigured in a creative act. Examples are gene and stem cell technology, 
which have created new values of objectification and materialisation of the hu-
man body, as well as new and expanded markets for the biotechnology industry. 
The relation between medical research and industry has not only produced new 
diagnostic methods and treatments, but has also projected the scientists’ values 
onto the public, in regard to how they relate to the human body.1 Biotechnologi-
cal research provides a good opportunity to study, from a cultural perspective, 
how new technologies reconfigure bodies into new states.2 In the article, the term 
’reconfiguration’ is used to study the evolving relationship between human and 
animal bodies, and how these bodies alter the manner in which we might refer 
to them.3  
The article is based on a study of Swedish scientific work with xenotransplan-
tation in the 1990s: A biotechnology where cells, tissue and organs from animals 
are transplanted to humans.4 The Swedish case is used to study how the field 
of xenotransplantation evolved in the 1990s, as well as how human and animal 
bodies were reconfigured in the process.5 In xenotransplantation, this reconfigu-
ration concerns not only the human body, but also the animal body, which is pro-
duced and recharged with new values and new understandings.6 This is evident 
in the perspectives taken by actor-network theory (ANT), where the nonhuman 
actors; animal cells, tissue and organs, have an energy that can affect human 
actors.7 As researchers transform and transplant these nonhuman actors to pa-
tients, the patient’s body becomes a part of a wider network of other actors, and it 
is within this wider network that the relationships between different bodies are 
1 Martin 1994.
2 Gilbert 2008; Lederer 2008.
3 Berg and Timmermans 2000; Bowen 2005; Olesen and Markussen 2003.
4 The article reports on work carried out as part of the project ‘Impact of Citizen Participation on Decision-
Making in a Knowledge Intensive Policy Field’ (CIT-PART, Project Nr. SSH-225327), which is funded within 
the 7th Framework Programme from 2009–2012. I thank the European Commission for their generous 
support of this research project. More information is available at the project website <www.cit-part.at>.
5 In the beginning of the 1990s Swedish researchers were at the forefront of international xenotransplanta-
tion research. At Karolinska University Hospital, researchers carried out clinical trials in which ten patients 
with diabetes underwent transplant surgery with pig cells producing insulin. At Sahlgrenska University 
Hospital, Gothenburg, researchers carried out two clinical trials where a pig kidney was connected to a 
patient and the human blood streamed through the kidney. At the time Sweden had between 10 and 15 
scientific groups that were working in international networks within this medical science. For a presen-
tation of the development of xenotransplantation in Sweden and internationally, see Brown and Beynon-
Jones 2010; Deschamps et al. 2005; Lanza and Cooper 1998; McLean and Williamson 2005; Persson and 
Welin 2008; SOU 1999:120.
6 Fox 2005; Twine 2010.
7 Berg and Timmermans 2000; Latour 1992.
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challenged. The human and the animal body are in this way not fixed and stable 
objects. Instead these bodies are seen as active surfaces where different biologi-
cal and cultural forces have the possibility of interconnecting with each other.8 
The reconfigured body is an actor that is affected by other human and nonhuman 
actors in unstable networks.  
In the article, the reconfiguration of human and animal bodies is studied 
through three different thematic issues of xenotransplantation research conduc-
ted in Sweden in the 1990s and early 2000s. The first issue concerns how the pig 
was introduced as a donor animal in xenotransplantation and, at the same time, 
dehumanized in relation to what is human. Baboons and chimpanzees that had 
previously been used in xenotransplantation now became an ethically problema-
tic choice and were conversely humanized. The second issue concerns the in-
troduction of transgenic and cloned pigs as commoditized objects. This biotech-
nological development reconfigured the pig’s cells, tissue and organs to become 
more human-like. The third issue concerns the risk that transplanted patients 
could be infected by PERV, Pig Endogenous RetroVirus (henceforth referred to as 
retrovirus) carried by the pigs used for xenotransplantation. As a consequence 
of this third issue, the human body became part of a network within which both 
animals and retrovirus were present. The issues are not separated in time; rather 
they are studied as overlapping activities during the 1990s.
Methods
Two different data categories have been used for the analysis. The first category 
comprises articles in newspapers and research journals presenting the research. 
The second category comprises interviews with researchers, politicians and a 
representative of an animal rights organization, involved in questions concerning 
xenotransplantation in Sweden in the 1990s. Newspapers and research journals 
offer an insight into the nature of the discussion at that time. Interviews made it 
possible for involved interviewees to reconsider and revaluate the central topics 
that prevailed more than ten years ago. Combining these two sets of data, the 
analysis in the article presents different perspectives on how the reconfiguration 
of human and animal bodies developed in the selected period. 
Swedish newspapers were collected through search engines on Internet using 
the search word ”xenotransplantation” during the time from 1995 to 2002. Texts 
dealing with topics central to this article were then selected and analysed. Ar-
ticles from international journals were collected in those cases where Swedish 
8 Bowen 2005; Braidotti 2002; Olesen and Markussen 2003.
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newspapers referred to international articles.9 Fifteen interviews ranging from 
40 minutes to 2 hours in length were carried out during 2009 and 2010. The in-
terviewees were medical researchers, researchers in the field of humanities and 
social sciences working with the medical researchers, politicians and one repre-
sentative for an animal rights organization. The interviews were tape recorded 
and transcribed. All the interviews were conducted with a list of questions con-
cerning how xenotransplantation research developed in Sweden in the 1990s.10 
Through the empirical material the main focus has been to explore the discourses 
on how the relationships between human and animal bodies were challenged in 
different cultural contexts in the 1990s and early 2000s. These discourses in the 
material have been analysed by thematizing them into the three different issues 
referred to above.
equal, but not too equal
One of the major problems with transplantation of animal organs into human 
bodies is the compatibility between these two biologically different objects. Re-
searchers have focused on the problem of immunosuppression: that the cell, tis-
sue or organ is rejected when adaptation to the new human environment does not 
succeed due to the efficiency of the immune system. The existence of concrete 
biological facts regarding the incompatibility between animal and human flesh 
made it possible to categorize the human as something different from the animal. 
Many of the earlier xenotransplantation experiments had used kidneys, hearts or 
livers from nonhuman primates such as baboons or chimpanzees in an attempt to 
overcome this disparity. But at the beginning of the 1990s, there was a discussion 
among the medical researchers at Sahlgrenska University Hospital in Gothen-
burg, concerning the use of nonhuman primates.
In 1995 the researchers at Sahlgrenska University Hospital connected two pa-
tients’ bloodstreams to pig kidneys as part of a medical trial. The kidneys were 
placed beside the patients in a box. In the first clinical trial, the human blood 
streamed through the kidney for one hour and fifteen minutes.11 Before the trial 
started, the researchers discussed which donor animal to use. One of the direc-
tors of the research team remembers the discussions about using pigs and not 
nonhuman primates: 
Researcher: “Considering the number of pigs that we eat, it wasn’t so strange 
to use that animal. However, we felt very strongly that it was impossible to use 
9 This data was presented in an earlier report, see Hansson 2003.
10 The material has been presented in Hansson and Lundin 2011.
11 Hansson 2003.
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nonhuman primates. Even though it was likely that it would be easier to use a 
kidney from a nonhuman primate than from a pig, though I have no evidence 
of that, we just felt that it was not ethically acceptable. There were several in 
our group who felt this way. It is difficult when you have human-like structu-
res, so to speak”.
Kristofer Hansson: “You talked about this at the beginning of the project”?
Researcher: “Yes, we did. We talked about all sorts of animals. We read a 
lot about different kinds of animals and concluded that we would work with 
pigs.”12
The medical researcher in the interview refers to the fact that much of the di-
scussion in Sweden at the beginning of the 1990s concerned the origin of the do-
nor animal. This discussion focused upon nonhuman primates being too similar 
to humans.13 The earlier donor animals, baboons and chimpanzees, were now 
seen as having too human-like a structure. In this way, the researchers projected 
human characteristics onto the nonhuman primates: the baboon and chimpan-
zee became anthropomorphized.14 The human characteristic was categorized as 
closer to what had been distinguished and defined as nature in earlier xenot-
ransplantation experiments. Not only was the relation between the two species 
discussed, but it also became impossible to use nonhuman primates in medical 
trials.
During the discussion about the close links between humans and nonhuman 
primates, the dualism between human and pig was also more clearly identified. 
As donor animals, pigs were considered a better choice than primates, because 
they were not too similar to what was categorized as human. As pointed out 
by the medical researcher, it is an animal that we eat. In this way, there was a 
ranking between animals, where the nonhuman primates were ranked higher as 
well as closer to humans. Following the same line of reasoning, pigs were ranked 
lower. To be able to use the pig in biotechnological research it was important to 
categorize the animal as something less-than-human and to raise the question 
of where to allocate the difficult notion of humanness in relation to the various 
donor animals at hand for the researchers.15
Among researchers and in the media, this categorization of pigs was something 
often discussed from the perspective that pigs were already being reared for meat 
12 The interviews were conducted at the researcher’s workplace, and a tape recorder was used (Interview: 
02.03.2010).
13 Other problems with using nonhuman primates were that they cannot be bred fast enough, and that they 
are an endangered species.  
14 Löfgren 1985.
15 Butler 2004.
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production. In the Swedish newspaper Dagens Nyheter, a reporter wrote in 1995: 
“There are few ethical problems working with pigs,”16 pointing out that since 
we already use pigs for meat production, there are few ethical problems in using 
them for medical purposes. While pigs were considered good donors, because 
their organs are equal in size to human organs and they breed quickly, they were 
in this way dehumanized.17 This dehumanization became a way of making it 
16 Dagens Nyheter 04.02.1995.
17 Plumwood 1993.
Fig. 1. The pig’s body was recharged with new and ethically acceptable values that made it pos-
sible to use the cells, tissue and organs in the human body. Photo: The author.
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ethically acceptable to use the pig in medical trials, but this dehumanization 
also came to function as a defence of a certain way of defining humaneness. 
In identifying the difference between the human body and the cells, tissue and 
organs from the pig, the unknown became mouldable and manageable and thus 
the possibility of using the pig as a future organ supply for the human body was 
created.18 The pig’s body was recharged with new and ethically acceptable values 
that made it possible to use the cells, tissue and organs in the human body. 
The pig as a factory
Even if the human/animal relation became mouldable and manageable by poin-
ting out the differences and similarities between the human, the pig and the non-
human primates – transgenic and cloned animals would subsequently change 
this human/animal relation. Much of the hope for success with xenotransplanta-
tion in the 1990s was abandoned in favour of producing transgenic animals, and 
later cloned animals, in an attempt to get control of immunosuppression. The 
Cambridge based company Imutran, and the director of research David White, 
injected human DNA into fertilized sow eggs and a transgenic pig was born in 
1992. In 1995, the USA company Nextran also developed transgenic pigs. The 
Edinburgh based company PPL Therapeutics, who cloned a sheep named Dolly, 
also cloned the first pigs by the beginning of the year 2000. More companies suc-
ceeded in cloning pigs in 2001 and 2002.19 In order to understand these techno-
logical changes from a cultural perspective, it is essential to focus on the dissolu-
tion of boundaries between human/animal, as well as between organic/machine. 
The redefinition of the human and the humaneness can be discussed through the 
commoditization of the transgenic and cloned animals, a perspective that will be 
discussed in relation to the anthropologist Sarah Franklin’s discussion on how 
cloning became a genetic capital.20 
Franklin points out that it is not Dolly the sheep, seen as an animal, that is 
the source of the genetic capital, but the knowledge of nuclear transfer techno-
logy. The knowledge of an animal’s reproduction has shifted to the companies 
that can make a profit. Furthermore, the cloning has altered the commodifying 
genealogy from a linear to a non-linear relation concerning the animal’s repro-
duction, where its mother can genetically be its sister.21 The sociologist Richard 
Twine clarifies this last point when he writes that: “Capitalization speculates for 
opportunity through the refutation of previously naturalized evolutionary time 
18 Åkesson 2000.
19 Brown and Beynon-Jones 2010; Hansson 2003; Persson and Welin 2008.
20 Franklin 2007.
21 Franklin 2007.
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and linear genealogy”.22 The capitalization of transgenic and cloned pigs is a 
way of seeking new patterns for the use of the animal, and the biotechnology 
companies are striving against something that is not traditional dualism between 
what is a human body and what is an animal body. This form of capitalization 
recreates an old metaphor where pigs and other animals are seen as factory farms 
capable of producing cells, tissue and organs for people who are sick and in need 
of treatment.23 The transgenic and the cloned pig are good examples of how the 
researchers saw this animal as a potential factory farm. 
After the first transgenic pig was born in 1992, David White succeeded in 
producing a second transgenic pig in 1995. This was highlighted in the Swedish 
tabloid Aftonbladet: “The pig is still a pig, it looks like a normal pig. It is only 
the pig’s organs that have become more human-like. The organs fit better in this 
way in the human body than they did before”.24 A transgenic pig’s organs became 
more flexible and could now fit both pig and human.25 Through the transforma-
tion of the pig’s cells, tissue and organs, they now became more like human cells, 
tissue and organs. The new technique initiated a change of equality between hu-
man and animal. This was somewhat opposed to the dehumanization of the pig, 
which has previously been discussed. 
At Lund University a research group planned transplantations of pig cells 
to patients with Parkinson’s disease. Clinical trials were never realized, but the 
research group conducted animal testing with immature pig cells transplanted 
into mice and rats, and they also experimented with transplantations from pig to 
pig. In the beginning, the embryos came from normal pig strains, but the research 
group had access to some of the transgenic pigs. The director of the research team 
pointed out in the interview: “The goal was to examine the feasibility of doing 
this with patients and to understand the mechanisms behind rejection, and to 
understand the biology. How the nerve cells fit, so to speak”.26 Now, the dualism 
between the human and the animal body was being challenged on a cellular 
level, as the project focused on studying how different nerve cells are rejected 
and how they fit together. Human and pig cells were seen as something similar, 
and on a cellular level the human and the pig became more comparable. The me-
dical researchers now looked for different technologies and methods to change 
the dualism between the different objects such as mice, rats, pigs and humans. 
Animal reproduction alone did not alter the relation between human and animal, 
but the different techniques and methods of using the animal were also vital for 
the reconfiguration of bodies. In order to succeed, the researchers needed to fit 
22 Twine 2010, p. 101.
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human and animal cells together. It was also necessary to dissolve the boundaries 
separating human and animal.
The company PPL Therapeutics succeeded in cloning a pig on March 5, 2000. 
The clones were named Christa, (after Christan Barnard who carried out the first 
human to human heart transplantation in 1967), Alexis and Carrel, (after Alexis 
Carrel who received the Nobel Prize in 1912 for his transplantation research), 
and Millie and Dotcom. Millie and Dotcom were symbolic names that related to 
the economic growth of the Internet companies at the beginning of the new mil-
lennium. The names can be seen as a form of popularization where the biotech-
nological knowledge was translated into something concrete that investors could 
relate to.27 However, the cloned pig did not become a success. At the beginning 
of  the year 2000 most countries that had continued with xenotransplantation re-
search, had also introduced a moratorium for clinical and experimental trials on 
humans. In Sweden the moratorium fragmented the research groups. At the same 
time stem cell research came as a new and promising biotechnological research 
that was said to solve the same medical problems as xenotransplantation. By the 
millennium stem cell researchers had captured the investors’ interest.  
dangerous actors
In the middle of the 1990s, new scientific findings emerged, drawing attention to 
the fact that cells, tissue and organs from animals contain retrovirus that could 
infect the transplanted patient. They in their turn could infect others and in 
worst-case scenario, start a global epidemic. In the countries performing or plan-
ning medical trials at the time, a moratorium was introduced in anticipation of 
new regulations. Many countries also started policy processes concerning calling 
off the moratorium and continuing with clinical trials in xenotransplantation. 
But when the policy processes had almost concluded by the end of the 1990s and 
beginning of the 2000s, the interest in xenotransplantation was weak.28 In Swe-
den the moratorium came about in 1997 as an agreement among the researchers.29 
As such it led to a difficult time for the Swedish researchers, and no official or 
publicized transplantations with animal organs have been carried out since the 
1990s.30
27 Hansson 2005.
28 Brown and Beynon-Jones 2010.
29 Hansson and Lundin 2011.
30 However since the moratorium, there have been xenotransplantations with cells and tissue in different 
parts of the world (Brown and Beynon-Jones 2010; Persson and Welin 2008).
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In 1998, the journal Nature had a thematic issue on xenotransplantation, and 
presented the scientific debate on the risks of the technology. Different resear-
chers' points of view were presented:
“Paul Herrling, scientific director of Novartis, says the Hong Kong flu outbreak 
shows “that the risk from other sources is much greater, and that the added 
risk in view of the life-saving nature of a successful xenotransplantation might 
be minimal”. Other researchers are less sanguine. “I take the same data and 
turn it around, saying ‘look, this can happen’”, says virologist Robin Weiss”.
[…]
“He argues that activation of animal viruses might be favoured under trans-
plant conditions, as these remove many barriers to natural means of infection 
[…] “I’m not saying you shouldn’t do this [clinical trials of xenotransplanta-
tion], I’m asking you, ‘have you stopped to think’?”, says Weiss.”31
The discussions focused upon the questions whether there was a natural barrier 
between humans and animals, or if we, as humans, are interlocked in a network 
within which nature is seen as an intrinsic part, and are therefore exposed to 
the dangers of virus. Could there be barriers to natural means of infection that 
would be removed with xenotransplantation? Hong Kong flu, HIV and the con-
nection between BSE (bovine spongiform encephalopathy), also called mad cow 
disease, and Creutzfeld Jacobs syndrome, were all serious diseases used in the 
media to show that animals had infected humans. However, in the article above 
these examples were used by both Herrling and Weiss, and in this way they re-
presented opposite views.
According to the media discussion, the pig became a dangerous object threa-
tening humankind. While the biotechnological researchers tried to control the 
processes around xenotransplantation, the risk for retrovirus was an unforeseen 
and uncontrollable consequence for the researchers.32 With an ANT perspective, 
as presented in the beginning of the article, it is possible to see how the resear-
chers, as actors, could not fully control other actors such as the retrovirus. The re-
trovirus is, in the ANT analysis, seen as a nonhuman actor comprising an energy 
that might affect the outcome of the medical trials in different, and unexpected, 
ways.33 In xenotransplantation other nonhuman actors affected the outcome, for 
example the problem of immunosuppression and cells, tissue or organs behaving 
in ways the researchers could not fully control. But the retrovirus was unique; 
it was an actor that contained a greater risk, as it was also able to infect a third 
party.
31 Nature 22.01.1998, p. 321.
32 Twine 2010.
33 Goodman 2001.
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The ANT perspective highlights how research and patients’ bodies are only 
part of a wider network of other actors. In this perspective the relationship bet-
ween human and animal bodies is once again questioned. One of the directors in 
the research team in Gothenburg explains how he changed his views, and started 
to see retrovirus as something that the researchers could not completely control, 
a perspective that a medical ethicist had pointed out to him:
“[The medical ethicist] had this thesis that we must consider retroviral epi-
demic as a plausible result. So we had to try to find ways of preventing or 
minimizing this. I think I also got into that line of reasoning very early. I can’t 
remember who came up with the idea first, but it just isn’t possible that the 
risk is so small that it is non-existent.”34 
The bodies and organs can be seen as what Lynda Birke, researcher in feminist 
science studies, calls “black boxes”. The medical researchers can view these 
black boxes in terms of input or output, but what happens inside the box remains 
hidden from their view.35 The researcher cannot predict or know all the conse-
quences of what he or she is doing. Using this concept in relation to the xeno-
transplantation case is however not equivalent to a perception of the human or 
the animal body as a closed system uncontrolled by the researchers. Rather, the 
term black box emphasizes that researchers cannot have insight into all areas of 
biology, and in parallel, biology can influence the development of the network in 
different and unpredictable ways. The risk for retrovirus can be seen as a know-
ledge that once again reconfigures the human body, and not as a rational and 
predictable object, but more like an irrational animal.36 
boundless bodies
In an interview, the sociologist Nicholas Gane and the philosopher Donna Hara-
way paraphrase the sociologist Bruno Latour’s “we have never been modern”37, 
when they point out that “we have never been human”.38 Taking xenotransplan-
tation as an example, this kind of biotechnological research seems to bring the ar-
gument further. The use of cells, tissue and organs from pigs in medical trials and 
experiments in laboratories, call into question the boundaries between these spe-
cies. Being objects in flexible systems, both the human body and the pig’s body 
34 Interview: 02.03.2010.
35 Birke 1999.
36 Gane and Haraway 2006, Murray 2006.
37 Latour 1993.
38 Gane and Haraway 2006.
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are doomed to be reconfigured. However, the patients that have gone through 
xenotransplantations strive to overcome the boundlessness that they experience. 
This was noticed by the ethnologist Susanne Lundin while interviewing patients 
with diabetes, who in the beginning of the 1990s received transplants of pancrea-
tic islets from pigs, she describes how these patients strived to find manageable 
definitions after being transplanted:
“It is clear that my informants are searching for manageable definitions of 
what is foreign and what is their own. They share a will to find principles for 
how to handle matter from a foreign species. In this context, the body is a cen-
tral point. For when biotechnology makes it possible to transgress and even 
erase fixed boundaries, between different bodies and life forms, a need arises 
to place oneself in a meaning-creating system. As we have seen, this applies 
to donations and transplants in general, but it is seen with particular clarity 
in the case of xenotransplants.”39
However for biotechnological development, the reconfiguring of the human and 
animal bodies, and thus also the changing relationship between these two bo-
dies, was central to the creative processes of discovering new treatments. Such a 
perspective opens up different aspects. The boundlessness between bodies and 
objects is the desirable approach, a place where the pig’s body can be objectified 
in new ways and the researchers and the biotechnology companies can create 
biomedicine that can be commoditized. For the medical researchers it is central 
to challenge the traditional dualism between human and animal. The meaning-
creating system for the medical researchers is, in contrast to the patient, the 
boundless body. 
The reconfiguration of objects is an important part of how biotechnological 
research constantly creates new objects. It is something other than the patients 
searching for manageable definitions of what is foreign; instead it is the foreign 
that is of interest.40 As the sociologist Bryan S. Turner points out: “Technology 
appropriates nature by alienation: that is by reconstituting it as an object. But in 
the alienation of nature, ‘Man’ opens up the possibility of working on the body, of 
transforming human ontology”.41 It is vital to point out the variance in patient’s 
views of how to handle this boundlessness. It is also important to discuss which 
networks make it possible for biotechnological research to strive for a reconfigu-
ring of the body.
39 Lundin 1999, p. 20-21.
40 Lundin 1999.
41 Turner 2007, p. 23.
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concluding thoughts
Animals perceived as biotechnological matter are in many different ways chal-
lenging the relationship between human and animal. The xenotransplantation 
research in the 1990s is only one example, but one that gives us many different 
perspectives on how to understand the challenges faced by dualism. Three is-
sues have been pointed out in the article: the use of pigs in xenotransplantation, 
transgenic and cloned pigs, and the risk for retrovirus. Vital for the two first is-
sues is a research and commodification process, where the reconfiguration of 
the animal body is made possible by using the bodily objects as cells, tissue and 
organ donors. The pig as biotechnological matter reconfigures both the human 
and the animal body, and it seems that a more boundless body appears among the 
researchers and biotechnological companies. Creative possibilities can be found 
in this boundless body as well, and new medical treatments can emerge. The 
third issue relates to a boundless body, but in contrast to the promising prospects 
of supplies for medical treatment the transgressive body would now become a 
threat. In the 1990s the researchers could not control the retrovirus and this risk 
hindered the development of xenotransplantation. Analysing the process from 
three different perspectives, it is central to see how the reconfiguration of objects 
is an on-going cultural process that questions our perspectives on what is ontolo-
gically a human/animal body. This biological process is not entirely social in its 
nature, but also cultural. When the biological entities are questioned and actually 
transformed, new body objects emerge.
 
* The author would like to thank the reviewer for the comments that helped to 
improve the manuscript. Thanks also to Anne Leonora Blaakilde, Aske Juul Las-
sen, Monica Libell, Niclas Hagen, Åsa Alftberg, Andrea Landström and Teresa 
Landström for insightful comments on previous manuscripts. 
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